Login to Your Account



Amgen: Roche Drug Lurking In Shadows As Aranesp Grows Up

By Randall Osborne


Monday, October 27, 2003

The trouble started in mid-October. That's when the price of Amgen Inc.'s shares, which had been at about $67, fell like autumn leaves, dipping just below $62 before an upsurge became evident in the first part of last week.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription